After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Packaged Foods industry segment, falling under the Consumer Defensive sector. The current market capitalization of Chromadex Corp is $653.08M. A total of 18.66 million shares were traded on the day, compared to an average of 457.04K shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, CDXC has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Jaksch Frank L Jr sold 37,161 shares of CDXC for 6.19 per share on Dec 13 ’24. After the transaction, the Director now owns 244,179 company shares. In a previous transaction on Dec 13 ’24, Frank Jaksch Jr. bought 37,161 shares at 6.19 per share.
Among the insiders who bought shares, Pamir Ozan acquired of 2,907 shares on Nov 22 ’24 at a per-share price of $7.36. This resulted in the Chief Financial Officer holding 2,907 shares of CDXC after the transaction. In another insider transaction, Patrick Kristin sold 23,000 shares at $3.57 per share on Aug 23 ’24. Company shares held by the Director now total 0.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for CDXC in the last 3 months, the mean price target is $8.70 with high estimates of $12.00 and low estimates of $6.80. In terms of 52-week highs and lows, CDXC has a high of $7.97 and a low of $1.57.
As of this writing, CDXC has an earnings estimate of $0.02 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of $0.03 per share and a lower estimate of $0.0.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CDXC’s latest balance sheet shows that the firm has $28.02M in Cash & Short Term Investments as of fiscal 2021. There were $4.70M in debt and $17.61M in liabilities at the time. Its Book Value Per Share was $0.45, while its Total Shareholder’s Equity was $31.73M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDXC is Buy with a score of 5.00.
